MedPath

Study to Compare Reduction in Pain After Surgery With and Without Local Anesthesia During Laparoscopy

Not Applicable
Conditions
Post Operative Pain
Interventions
Drug: Saline will be injected at the study port site prior to incision
Drug: 0.25% bupivicaine will be injected at the study port site prior to incision
Drug: Saline will be in injected into the port site prior to closure
Drug: 0.25% bupivicaine will be injected into the port site prior to closure
Registration Number
NCT01452633
Lead Sponsor
Stony Brook University
Brief Summary

This study will help to answer the question, "Does injecting local anesthetic before laparoscopic instrument ports are placed decrease pain after surgery?" Patients participating will be randomly assigned to receive local anesthetic or saline injection at the site of a laparoscopic instrument port as part of their planned surgery. After surgery at 4 and 24 hours the patient will be asked to rate their pain on a simple chart.

Detailed Description

The literature is divided on the efficacy of preincisional local analgesia injections at laparoscopic port sites to decrease post operative pain. One reason for this lack of a clear conclusion is the fact that prior studies included small and large port sizes. Many small port sites have little pain associated with them so showing a reduction with medicine is statistically difficult. The investigators have noted that larger, lateral port sites which require fascial closure are the sites that patients consistently note pain at. Our protocol will include the use of 0.25% marcaine injections at all the surgical ports other than the large lateral port used for gynecologic laparoscopy. Patients would then be randomized and surgeons would be blinded as to which patients receive the marcaine or a saline injection at the large lateral port site. Visual analog pain scales will be assessed at 4 and 24 hours after surgery. An additional two arms have been added to include 50 patients randomized to 0.25% marcaine or saline injection just prior to incisional closure in the absence of any preincisional intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • patients undergoing laparoscopic surgery
Exclusion Criteria
  • Cardiovascular instability
  • malignancies
  • pulmonary conditions incompatible with laparoscopic surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Preincision PlaceboSaline will be injected at the study port site prior to incisionThis group of patients will receive saline injection at study port site before incision
Preincision Marcaine0.25% bupivicaine will be injected at the study port site prior to incisionThis group will receive marcaine injection at the study port site prior to incision
Postincision Placebo0.25% bupivicaine will be injected at the study port site prior to incisionThis group of patients will receive preincisional marcaine and then saline injection at study port site prior to closure
Postincision PlaceboSaline will be in injected into the port site prior to closureThis group of patients will receive preincisional marcaine and then saline injection at study port site prior to closure
Postincision marcaine0.25% bupivicaine will be injected at the study port site prior to incisionThis group will receive preincisional marcaine and then marcaine injection at study port site prior to closure
Postincision marcaine0.25% bupivicaine will be injected into the port site prior to closureThis group will receive preincisional marcaine and then marcaine injection at study port site prior to closure
Primary Outcome Measures
NameTimeMethod
Reduction in post-operative pain at large lateral port sites4 and 24 hours after surgery

visual analog scoring of post-operative pain in a control and a treatment group

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stony Brook University Medical Center

🇺🇸

Stony Brook, New York, United States

© Copyright 2025. All Rights Reserved by MedPath